Recent international trends in psychotropic medication prescriptions for children and adolescents

European Child and Adolescent Psychiatry

Volumn 24, Issue 6, 2015, Pages 635-640

  Steinhausen, Hans Christoph ^a,b,c  

^a Aalborg Psykiatriske Sygehus   (Denmark)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adolescents; Antidepressants; Antipsychotics; Anxiolytics; Children; Psychopharmacology; Stimulants

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; CENTRAL STIMULANT AGENT;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD PSYCHIATRY; CHILDHOOD DISEASE; DENMARK; HUMAN; ICELAND; MENTAL DISEASE; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; NETHERLANDS; PRESCRIPTION; PREVALENCE; SWEDEN; UNITED STATES; EUROPE; INTERNATIONAL COOPERATION; MENTAL DISORDERS;

ADOLESCENT; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DRUG PRESCRIPTIONS; EUROPE; HUMANS; INTERNATIONALITY; MENTAL DISORDERS; PSYCHOTROPIC DRUGS; UNITED STATES;

EID: 84930272053     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-014-0631-y     Document Type: Article

References (33)

1. Rapoport JL (2013) Pediatric psychopharmacology: too much or too little? World Psychiatry 12:118–123
2. Steinhausen HC (2013) A European perspective on paedo-psychiatric pharmacoepidemiology. World Psychiatry 12:131–132
3. Taylor E (2013) Pediatric psychopharmacology: too much and too little. World Psychiatry 12:124–125
4. Mancini J, Thirion X, Masut A, Saillard C, Pradel V, Romain F, Pastor MJ, Coudert C, Micallef J (2006) Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002. Pharmacoepidemiol Drug Saf 15:494–503
5. Zoega H, Baldursson G, Hrafnkelsson B, Almarsdottir AB, Valdimarsdottir U, Halldorsson M (2009) Psychotropic drug use among Icelandic children: a nationwide population-based study. J Child Adolesc Psychopharmacol 19:757–764
6. Olfson M, He JP, Merikangas KR (2013) Psychotropic medication treatment of adolescents: results from the national comorbidity survey-adolescent supplement. J Am Acad Child Adolesc Psychiatry 52:378–388
7. Wong IC, Murray ML, Camilleri-Novak D, Stephens P (2004) Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child 89:1131–1132
8. Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC (2008) A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2:26 1753-2000-2-26
9. Zito JM, Safer DJ, DosReis S, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle MA (2003) Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med 157:17–25
10. Hugtenburg JG, Heerdink ER, Egberts AC (2004) Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol 60:377–379
11. Steinhausen HC, Bisgaard C (2014) Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark. Acta Psychiatr Scand 129:221–231
12. Percudani M, Barbui C, Fortino I, Petrovich L (2005) Worrying patterns of out-patient psychotropic drug prescribing in children and adolescents. Psychother Psychosom 74:189–190
13. Zito JM, Tobi H, de Jong-van den Berg LT, Fegert JM, Safer DJ, Janhsen K, Hansen DG, Gardner JF, Glaeske G (2006) Antidepressant prevalence for youths: a multi-national comparison. Pharmacoepidemiol Drug Saf 15:793–798
14. Murray ML, de Vries CS, Wong IC (2004) A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child 89:1098–1102
15. Vitiello B, Zuvekas SH, Norquist GS (2006) National estimates of antidepressant medication use among US children, 1997–2002. J Am Acad Child Adolesc Psychiatry 45:271–279
16. Olfson M, Marcus SC (2009) National patterns in antidepressant medication treatment. Arch Gen Psychiatry 66:848–856
17. Fegert JM, Kolch M, Zito JM, Glaeske G, Janhsen K (2006) Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol 16:197–206
18. Dorks M, Langner I, Dittmann U, Timmer A, Garbe E (2013) Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study. Eur Child Adolesc Psychiatry 22:511–518
19. Deurell M, Weischer M, Pagsberg AK, Labianca J (2008) The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey. Nord J Psychiatry 62:472–480
20. Rani F, Murray ML, Byrne PJ, Wong IC (2008) Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 121:1002–1009
21. Olfson M, Blanco C, Liu L, Moreno C, Laje G (2006) National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 63:679–685
22. Pringsheim T, Lam D, Patten SB (2011) The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005–2009. J Child Adolesc Psychopharmacol 21:537–543
23. Patel NC, Sanchez RJ, Johnsrud MT, Crismon ML (2002) Trends in antipsychotic use in a Texas medicaid population of children and adolescents: 1996 to 2000. J Child Adolesc Psychopharmacol 12:221–229
24. Zoega H, Furu K, Halldorsson M, Thomsen PH, Sourander A, Martikainen JE (2011) Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand 123:360–367
25. Zito JM, Safer DJ, DosReis S, Gardner JF, Boles M, Lynch F (2000) Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283:1025–1030
26. Zuvekas SH, Vitiello B (2012) Stimulant medication use in children: a 12-year perspective. Am J Psychiatry 169:160–166
27. Visser SN, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour RM, Perou R, Blumberg SJ (2014) Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. J Am Acad Child Adolesc Psychiatry 53:34–46
28. Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT (2001) Psychotropic medication in children: a study from the Netherlands. Pediatrics 108:E25
29. Knellwolf AL, Deligne J, Chiarotti F, Auleley GR, Palmieri S, Boisgard CB, Panei P, Autret-Leca E (2008) Prevalence and patterns of methylphenidate use in French children and adolescents. Eur J Clin Pharmacol 64:311–317
30. Schubert I, Koster I, Lehmkuhl G (2010) The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000–2007. Dtsch Arztebl Int 107:615–621
31. Zetterqvist J, Asherson P, Halldner L, Langstrom N, Larsson H (2013) Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006–2009. Acta Psychiatr Scand 128:70–77
32. Dalsgaard S, Nielsen HS, Simonsen M (2013) Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other Psychiatric disorders: a Danish register-based study. J Child Adolesc Psychopharmacol 23:432–439
33. Vitiello B (2008) An international perspective on pediatric psychopharmacology. Int Rev Psychiatry 20:121–126